首页 | 本学科首页   官方微博 | 高级检索  
     


Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature
Authors:Yarong Liu  Yu J. Kim  Natnaree Siriwon  Jennifer A. Rohrs  Zhiqiang Yu  Pin Wanga
Affiliation:1. Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California;2. Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, California;3. Department of Biomedical Engineering, University of Southern California, Los Angeles, California;4. School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, Guangdong, China
Abstract:
Keywords:active targeting nanoparticles  combretastatin A4 (CA‐4)  crosslinked multilamellar liposomal vesicle  doxorubicin (Dox)  nanomedicine  targeted drug combination therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号